ArticleFrontiers in pharmacology2021

Fisetin Attenuates Myocardial Ischemia-Reperfusion Injury by Activating the Reperfusion Injury Salvage Kinase (RISK) Signaling Pathway.

Karthi Shanmugam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.